Skip to main content

Norman Nagl, PhD

Medical Director,
Eisai, Inc
Medical Director, Eisai, Inc
Authored Items
Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis
Claudio Faria, PharmD, MPH, Curtis Wander, PharmD, Xuan Li, MS, Norman Nagl, PhD, Ali McBride, PharmD, MS
January/February 2014 Vol 7, No 1 in Original Research
Last modified: February 21, 2014